Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | +0.67% | -16.47% | -13.99% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.99% | 288M | |
+8.78% | 114B | |
+12.83% | 107B | |
-12.36% | 22.22B | |
-1.72% | 21.28B | |
-5.10% | 18.8B | |
-4.77% | 17.51B | |
-39.93% | 17.17B | |
+6.27% | 14.14B | |
+33.22% | 12.2B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics Names Kristin Yarema as CEO, Mark Gergen as Executive Chairman